MedSecurities Investment SAL at a glance
MedSecurities Investment SAL appears to be a Lebanon-registered investment firm (SAL) offering trading and investment services to local and regional clients. Public information and third-party verifications are limited.
MedSecurities Investment SAL reports a founding year of 2007 and a head office in Beirut, Lebanon. It lists 6 regulators and 0 trading platforms.
BrokerBazaar verdict
The entity has a significant historical regulatory footprint, but its DFSA authorisation was withdrawn in 2018 and a current retail brokerage operation could not be independently verified. The principal risk is therefore not that the historical DFSA licence was illegitimate; it is that presenting the entity today as an active Dubai-regulated broker would be inaccurate. The firm received DFSA authorisation F002645 on 11-Feb-2015 and operated from the DIFC with permissions covering arranging, advising, agency dealing, matched-principal dealing and custody. However, the DFSA records the authorisation as withdrawn on 04-Apr-2018. In Lebanon, MedSecurities Investment SAL remains identifiable in Banque du Liban's financial-institution records under number 51. However, a current CMA securities-brokerage licence could not be independently verified, and the available 2019 official CMA brokerage list does not include MedSecurities. Historical BankMed records also show that the securities business was subsequently migrated/consolidated into MedInvestment Bank. Therefore, MedSecurities Investment SAL should be classified as a historical/former Dubai-regulated brokerage entity rather than an active DFSA broker. Any current financial-services relationship should be checked against the exact legal entity currently responsible for the client's account.
Legal entities, regulation and licences
MedSecurities Investment SAL operates through 1 legal entity, each supervised separately. Your account is with one specific entity, so the protections you receive depend on which one onboards you, not on the group's strongest licence. Overall, the group is supervised by no regulator we could map to a public register.
Licence check: Not independently checked. This broker has submitted its details. BrokerBazaar has not yet independently checked them. A company registration or general business licence is not permission to offer regulated brokerage services; only the register entries linked in the table count.
Countries accepted and restricted
MedSecurities Investment SAL states that it accepts clients from Lebanon, Regional and International Clients — current eligibility NOT VERIFIED. Availability is decided per entity and can change without notice; residents of jurisdictions such as the USA, and often the EU and UK, are frequently excluded from offshore entities.
Trading products, platforms and account types
Instruments: Shares, Debentures, Warrants, Certificates, Options, Units, Futures, Structured Products. Platforms: Not disclosed. Account types: NOT VERIFIED.
Best-for tags assigned by our team: Lebanese Securities, Investment Products, Securities Brokerage, Institutional Investors, Historical BankMed Brokerage.
Minimum deposit, spreads, commissions and other charges
The minimum deposit is NOT VERIFIED. Spreads start from NOT VERIFIED and commission is NOT VERIFIED. Maximum leverage is NOT VERIFIED, subject to the cap of the entity that holds your account.
Swap-free / Islamic account: not specified. Swap type: not specified. Headline spreads are usually quoted for the most expensive account tier's cheapest instrument; compare total cost for your typical trade.
Deposits and withdrawals
Deposit methods: NOT VERIFIED. Withdrawal methods: NOT VERIFIED.
Withdrawal speed and fees are set by the entity and payment provider. Withdrawal delays are the most common complaint category on BrokerBazaar across all brokers; keep identity documents current and withdraw to the same method you deposited with where required by anti-money-laundering rules.
Execution model, negative balance protection and client money
Negative balance protection: Not specified. Scalping allowed: Not specified. Algorithmic trading allowed: Not specified. News trading allowed: Not specified. Hedging: not specified.
Client-money rules follow the regulator of the entity that holds your account. Check that regulator's rules on its register.
Complaints and dispute process
Formal complaints: info@medsecurities.co, historical general contact; NOT VERIFIED as a current dedicated complaints channel. Phone: +961 1 371333 — historical general contact; NOT VERIFIED as a current dedicated complaints channel. No current dedicated complaint email, complaints phone line, online complaint form or published resolution timeframe was independently verified. For a complaint concerning Lebanese operations, first contact MedSecurities using its published general contact details and request the formal complaints procedure in writing. Preserve account statements, transaction IDs, agreements, payment records and communications. For concerns connected to historical DIFC activity, note that the DFSA licence was withdrawn on 4 April 2018 and confirm the responsible legal entity before escalation.
If the broker does not resolve a complaint, escalate to the ombudsman or regulator of the entity that holds your account. BrokerBazaar's Dispute Support Desk can help you document and escalate a case.
Strengths and limitations
- Strength: Lebanese financial institution listed by Banque du Liban
- Strength: BDL Financial Institution No. 51
- Strength: Established as a BankMed brokerage subsidiary
- Strength: Historical securities brokerage operations
- Strength: Historical access to local, regional and international markets
- Strength: Historical distribution of investment products
- Strength: Historical private-placement services
- Strength: Historically authorised by the DFSA
- Strength: DFSA licence F002645
- Strength: DFSA licence originally granted in February 2015
- Strength: Broad historical DFSA investment permissions
- Strength: Historical custody permissions
- Strength: Historical matched-principal dealing permission
- Strength: Long-established BankMed group association
- Limitation: DFSA licence withdrawn on 04-Apr-2018
- Limitation: No current DFSA authorisation
- Limitation: Current retail brokerage offering not independently verified
- Limitation: Current minimum deposit not verified
- Limitation: Current leverage not verified
- Limitation: Current spreads not verified
- Limitation: Current commissions not verified
- Limitation: Current trading platform not verified
- Limitation: Current deposit methods not verified
- Limitation: Current withdrawal methods not verified
- Limitation: Current dedicated customer support not verified
- Limitation: Current dedicated website not verified
- Limitation: Current CMA brokerage licence not independently verified
- Limitation: 2019 CMA official brokerage list did not list MedSecurities Investment SAL
- Limitation: BankMed securities business was subsequently migrated/consolidated into MedInvestment Bank
- Limitation: Historical Dubai operations should not be represented as current UAE regulation
Who this broker suits, and who it does not
MedSecurities Investment SAL is most relevant to traders looking for: Lebanese Securities, Investment Products, Securities Brokerage, Institutional Investors, Historical BankMed Brokerage.
It is less suitable for anyone who needs a strict-tier regulator in their own country of residence, for residents of restricted jurisdictions, and for beginners who have not yet understood leverage and margin. Nothing on this page is personal financial advice.
MedSecurities Investment SAL change history
Every published fact change, with the previous value and the date it took effect. Each entry says whether the broker made the change itself or our editors checked it against an official source. Regulation and licence claims are always checked by an editor.
No fact changes recorded for MedSecurities Investment SAL yet. Changes appear here as soon as the broker updates its profile or our editors confirm a change.
Frequently asked questions about MedSecurities Investment SAL
Data sources. Broker submission, the regulator registers linked above, web-archive and domain records, and third-party traffic data. No independent licence check date is recorded yet. External ratings: Trustpilot N/A/5; WikiFX N/A/5; Apple App Store N/A/5; Google Play Store N/A/5.
Commercial disclosure. BrokerBazaar is independent and not owned by any broker. We may receive a referral fee if you open an account with MedSecurities Investment SAL through our links; this never affects scores or verification. How we make money. Trading leveraged products carries a high risk of loss.